Cocrystal Pharma, Inc.
(NASDAQ : COCP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. 0.19%138.701.9%$228.82m
MYLMylan NV -0.92%15.963.2%$108.31m
TEVATeva Pharmaceutical Industries Ltd. -0.09%11.202.0%$105.35m
BBIOBridgeBio Pharma, Inc. -1.35%30.010.0%$26.71m
RDYDr. Reddy's Laboratories Ltd. 0.95%51.942.0%$10.31m
COCPCocrystal Pharma, Inc. 8.07%1.730.0%$9.85m
TXMDTherapeuticsMD, Inc. 0.00%1.5322.1%$8.79m
ABEOAbeona Therapeutics, Inc. 2.14%3.474.5%$3.36m
TAROTaro Pharmaceutical Industries Ltd. -1.80%66.976.5%$2.26m
JAGXJaguar Health, Inc. 4.63%0.571.7%$1.99m
KINKindred Biosciences, Inc. -1.81%3.800.3%$1.95m
CPHIChina Pharma Holdings, Inc. -3.47%0.560.1%$1.92m
LFVNLifeVantage Corp. -0.23%13.003.3%$1.29m

Company Profile

Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.